Burlington, Ontario--(Newsfile Corp. - September 8, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to announce that Moira Ong has been appointed as Chief Financial Officer and Corporate Secretary and Vito Sanzone has been appointed as a Director of the Company.
Mr. Sanzone is currently the CEO. Mr. Sanzone has 25 years of experience in the health, wellness and fitness industry and has had executive roles in three performance nutrition mergers and acquisitions worth a combined $1 billion.
Ms. Ong has over 20 years' experience in financial reporting, compliance and audit. Ms. Ong has served as Vice President of Finance and Chief Financial Officer of private and publicly-listed entities since 2010 and assisted these companies with public listings processes, mergers and acquisitions.
The Company also announces that Shaun Power has resigned as Chief Financial Officer, Corporate Secretary and Director. The Company wishes to thank Mr. Power for his contributions to the Company.
About Promino
Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle Health now benefits from a new formulation that aims to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario.
For more information about Rejuvenate Muscle Activator and where to purchase, visit www.rejuvenatemuscle.com.
To learn more about Promino, visit www.drinkpromino.com.
Forward-Looking Statements
This news release contains forward-looking statements and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipates", "expects" and similar expressions. All statements other than statements of historical fact, included in this news release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
For further information about Promino:
Vito Sanzone, CEO, vsanzone@drinkpromino.com, 289-348-1970 ext. 222
Marc Charbin, Investor Relations, marc.charbin@loderockadvisors.com, 416-467-5229
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265349
SOURCE: Promino Nutritional Sciences, Inc.
